BDTX - CIK 0001701541
The table below shows Black Diamond Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.99M | $36.44M | $56.22M | $34.31M | $65.80M | $34.60M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $132.44M |
| $101.18M |
| $134.03M |
| $127.71M |
| $215.70M |
| $319.55M |
| Property, plant & equipment | $365.00K | $1.39M | $1.73M | $2.59M | $3.04M | $385.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $143.01M | $122.64M | $158.57M | $156.25M | $247.68M | $329.67M |
| Accounts payable | $579.00K | $4.01M | $2.32M | $1.88M | $4.11M | $2.54M |
| Total current liabilities | $15.73M | $20.57M | $19.65M | $15.26M | $23.64M | $14.22M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $30.80M | $39.35M | $41.83M | $40.56M | $51.78M | $21.91M |
| Retained earnings | -$464.74M | -$487.11M | -$417.43M | -$334.99M | -$243.82M | -$118.22M |
| Total equity | $112.21M | $83.28M | $116.74M | $115.69M | $195.90M | $307.76M |